Barcodes Are Us

November 29, 2022 AutoBot 0

BY KIM BELLARD Usually I write about things where I see some unexpected parallel to healthcare, or something just amazed me, or outraged me (there […]

No Image

Stay COVIDSafe

November 29, 2022 AutoBot 0

During the upcoming holidays it is important that we stay COVIDSafe. As we start to enjoy our summer, we need to be aware the next […]

Role of KOL influence

November 29, 2022 AutoBot 0

Why KOL Influence Drives KOL Engagement You have in front of you a syndicated KOL database of gargantuan proportions showing you everyone with any sort […]

No Image

New tentative approval for Amneal Pharms drug saxagliptin

November 29, 2022 AutoBot 0

[![saxagliptin structure](https://www.DrugPatentWatch.com/img/drug-structure/saxagliptin.png)](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generic ingredient in one branded drug marketed by Astrazeneca Ab and is included in one NDA. There are two patents […]

No Image

New tentative approval for Teva Pharms drug eltrombopag

November 29, 2022 AutoBot 0

[![eltrombopag structure](https://www.DrugPatentWatch.com/img/drug-structure/eltrombopag.png)](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generic ingredient in two branded drugs marketed by Novartis and is included in two NDAs. There are eight patents protecting […]